IGFR1 and PI3KCA have been identified as target genes of FOXO3a in a colon carcinoma cell line [115], which indicates that FOXO3a may activate PI3K–PKB signaling pathway by multiple mechanisms and it could contribute to drug resistance in colon cancer. This evidence concerns the gene FOXO3 and colonic neoplasm.